A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.

Name: A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.
License: Public Domain

National Institute of Allergy and Infectious Diseases (NIAID) · clinicaltrials

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

hiv-infections

hiv infections

ClinicalTrials.gov Show glossary Search for terms Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.

Record · ID 28432 · SHA-256 17c3746fc8cd5ac2
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.